News & Updates
Filter by Specialty:
Inhaled amikacin cuts VAP burden in mechanically ventilated patients
In critically ill patients who have been on invasive mechanical ventilation (IMV) for at least 3 days, a subsequent 3-day course of preventive inhaled amikacin reduced the burden of ventilator-associated pneumonia (VAP) during 28 days of follow-up, findings from the AMIKINHAL trial have shown.
Inhaled amikacin cuts VAP burden in mechanically ventilated patients
16 Jan 2024
Linezolid flops against benzathine penicillin G for early syphilis
In the treatment of patients with early syphilis, a 5-day course of linezolid does not appear to perform as well as the standard of care benzathine penicillin G (BPG), as shown in a study.
Linezolid flops against benzathine penicillin G for early syphilis
12 Jan 2024
mRNA boosters protect cancer patients against adverse COVID-19 outcomes
A prospective study from Singapore provides evidence of the clinical effectiveness of mRNA-based vaccines against COVID-19 in individuals with cancer.
mRNA boosters protect cancer patients against adverse COVID-19 outcomes
08 Jan 2024
Minority healthcare workers more exposed to COVID-19‒related stressors
Healthcare workers belonging to racial and ethnic minorities show greater exposure to several COVID-19‒related stressors, indicating a structural racism in the workforce, reports a study.
Minority healthcare workers more exposed to COVID-19‒related stressors
26 Dec 2023
Remdesivir shows no clear benefit in children with severe COVID-19
The antiviral remdesivir offers no clear benefit in the treatment of children with severe COVID-19, falling short of reducing the time spent in high dependency or intensive care unit (HD/ICU), according to a study from Singapore.